INVO Fertility (NASDAQ:IVF – Get Free Report) and Cigna Group (NYSE:CI – Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership and risk.
Volatility & Risk
INVO Fertility has a beta of 2.42, meaning that its share price is 142% more volatile than the S&P 500. Comparatively, Cigna Group has a beta of 0.25, meaning that its share price is 75% less volatile than the S&P 500.
Institutional & Insider Ownership
12.0% of INVO Fertility shares are owned by institutional investors. Comparatively, 87.0% of Cigna Group shares are owned by institutional investors. 0.4% of INVO Fertility shares are owned by company insiders. Comparatively, 0.6% of Cigna Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Profitability
This table compares INVO Fertility and Cigna Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| INVO Fertility | -116.29% | -85.54% | -31.05% |
| Cigna Group | 2.27% | 19.75% | 5.34% |
Valuation & Earnings
This table compares INVO Fertility and Cigna Group”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| INVO Fertility | $6.84 million | 0.19 | -$25.13 million | ($33.83) | -0.06 |
| Cigna Group | $274.90 billion | 0.29 | $5.96 billion | $24.17 | 12.48 |
Cigna Group has higher revenue and earnings than INVO Fertility. INVO Fertility is trading at a lower price-to-earnings ratio than Cigna Group, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of recent ratings and price targets for INVO Fertility and Cigna Group, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| INVO Fertility | 1 | 0 | 0 | 1 | 2.50 |
| Cigna Group | 0 | 8 | 14 | 0 | 2.64 |
INVO Fertility currently has a consensus target price of $320.00, suggesting a potential upside of 15,663.55%. Cigna Group has a consensus target price of $336.40, suggesting a potential upside of 11.51%. Given INVO Fertility’s higher possible upside, equities analysts clearly believe INVO Fertility is more favorable than Cigna Group.
Summary
Cigna Group beats INVO Fertility on 12 of the 15 factors compared between the two stocks.
About INVO Fertility
INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.
About Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Receive News & Ratings for INVO Fertility Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INVO Fertility and related companies with MarketBeat.com's FREE daily email newsletter.
